Our path to Pegami™
Next generation
psychedelic medicine
for mental health and wellbeing
OUR GOAL IS TO INCREASE THE SAFETY, TOLERABILITY, AND EFFICACY OF NEXT GENERATION PSYCHEDELIC MEDICINES FOR MENTAL HEALTH.
The mental health crisis
largest healthcare burden – 15% of
total disease burden in 2020
Call for Action
Our achievements so far
Investment: Seed round of 4.1M USD closed in Q2 2021 to finance the initial steps of the clinical development of PEGAMITM
Product: With PEGAMI™ we have created a safe and controllable way of providing patient-centered psychedelic therapy.
IP: In-human results from our studies point towards a best-in-class drug safety profile for various mental health problems, with primary focus on affective disorders – basis for solid and exclusive IP
Research: Independent academic research track at the University of Zurich with access to state-of-the-art labs and infrastructure via the Psychedelic Research & Therapy Development group led by Dr. Milan Scheidegger (Co-Founder)
Funding: Non-dilutive seed financing with research grants and private donations in excess of 1.5M CHF
Regulatory permissions: Obtained in 2019 from Swiss health authorities for the manufacturing and first in human trials with PEGAMI™
DRUG DEVELOPMENT ROADMAP
Completed
2021
2022
2023
2024
2025
As Transition to psychedelic psychotherapy: "The effect of psychedelic medicines is context-dependent. High quality therapeutic framing is required for optimal safety and efficacy." Find out about our Transformative Psychotherapy paradigm change.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean a feugiat felis. Vivamus commodo, ex in ullamcorper iaculis, velit tellus viverra mi, pulvinar vestibulum elit leo eu erat. Vivamus ac libero tincidunt, porta purus at, condimentum leo. Etiam massa leo, suscipit in tincidunt nec, laoreet at lacus.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean a feugiat felis. Vivamus commodo, ex in ullamcorper iaculis, velit tellus viverra mi, pulvinar vestibulum elit leo eu erat. Vivamus ac libero tincidunt, porta purus at, condimentum leo. Etiam massa leo, suscipit in tincidunt nec, laoreet at lacus.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean a feugiat felis. Vivamus commodo, ex in ullamcorper iaculis, velit tellus viverra mi, pulvinar vestibulum elit leo eu erat. Vivamus ac libero tincidunt, porta purus at, condimentum leo. Etiam massa leo, suscipit in tincidunt nec, laoreet at lacus.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean a feugiat felis. Vivamus commodo, ex in ullamcorper iaculis, velit tellus viverra mi, pulvinar vestibulum elit leo eu erat. Vivamus ac libero tincidunt, porta purus at, condimentum leo. Etiam massa leo, suscipit in tincidunt nec, laoreet at lacus.
Read further about
PSYCHEDELIC THERAPY
Our process-oriented Transformative Psychotherapy approach provides and alternative to widely used symptom-focused treatments in psychiatry, which have shown only limited efficacy.
It is less focused on specific symptoms and their substitution by psychotropic drugs, but aims at resolving maladaptive processes by empowering patients to access more flexible and balanced states of consciousness.